Cencora

Health Care Health Care Distributors Conshohocken, Pennsylvania Last filing Nov 25, 2025 · FY2026

                    Revenue
                    FY2025
                
$321.3B
                    
                    +9.3%
                    
                    Net income
                    FY2025
                
$1.6B
                    
                    +3.0%
                    
                    Total assets
                    FY2025
                
$76.6B
                    
                    +14.1%
                    
                    Operating cash flow
                    FY2025
                
$3.9B
                    
                    +11.2%

20 yrs · FY2007–FY2026 9 filed · 0 derived · 0 blank

1Y 3Y 5Y 10Y

Dollars % of revenue % of assets YoY % CAGR

Each cell as a share of that year’s total assets.

Balance Sheet

Assets, liabilities, and equity

10 accounts · 5 years

Total assets $76.6B

Total liabilities $76.6B

Shareholders equity $1.5B

Account	2026	2025	2024	2023	2022
Assets
Accounts Receivable	—	32.9%	35.6%	33.4%	32.6%
Property,Plant and Equipment	—	3.3%	3.3%	3.4%	3.8%
Goodwill	—	17.9%	13.9%	15.3%	15.0%
Intangible Assets	—	4.9%	—	—	—
Liabilities
Long Term Debt	—	9.8%	5.7%	6.6%	8.2%
Other Noncurrent Liabilities	—	4.8%	3.0%	3.0%	1.7%
Equity
Preferred Stock	—	0.0%	0.0%	0.0%	0.0%
Common Stock	—	0.0%	0.0%	0.0%	0.0%
Treasury Stock	—	13.5%	—	—	12.4%
Accumulated Other Comprehensive Income	—	-1.2%	—	—	—

Income Statement

Revenue, expense, and profitability

1 accounts · 5 years

Revenue $321.3B

Operating income $2.6B

Net income $1.6B

Account	2026	2025	2024	2023	2022	Trend
IncomeStatement
Income Tax Income Tax Expense	—	0.9%	—	—	—

Cash Flow Statement

Operating, investing, and financing flows

2 accounts · 5 years

Operating cash flow $3.9B

Investing cash flow $-5.0B

Financing cash flow $2.2B

Account	2026	2025	2024	2023	2022
CashFlow
Operating Activities Depreciation and Amortization	—	0.7%	0.7%	0.7%	0.7%
Operating Activities Changes In Operating Assets and Liabilities	—	8.7%	13.7%	17.3%	8.9%

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 5 years

Ratio	2026	2025	2024	2023	2022
Profitability
Gross margin	—	+3.6%	+3.4%	+3.4%	+3.5%
Operating margin	—	+0.8%	+0.7%	+0.9%	+1.0%
Net margin	—	+0.5%	+0.5%	+0.7%	+0.7%
FCF margin	—	+1.0%	+1.0%	+1.3%	+0.9%
Growth
Revenue CAGR (3y)	—	+10.4%	—	+11.4%	+9.9%
Returns
ROE	—	+103.1%	+233.6%	+334.3%	-803.0%
ROA	—	+2.0%	+2.2%	+2.8%	+3.0%
ROIC	—	+37.9%	+114.4%	+86.1%	+112.5%
Liquidity
Current ratio	—	0.90x	0.88x	0.88x	0.91x
Quick ratio	—	0.51x	0.50x	0.48x	0.50x
Leverage
D/E	—	50.79x	103.88x	119.84x	-267.35x
Interest coverage	—	—	—	—	—
Efficiency
Asset turnover	—	4.20x	4.38x	4.19x	4.22x
Cash conversion cycle	—	-12d	-11d	-12d	-11d

Valuation

Price against fundamentals

FY2026 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched

Cencora

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Recent price history